Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Sun Yat-sen University logo

Sun Yat-sen University

Status

Not yet enrolling

Conditions

Recurrent and Metastatic Nasopharyngeal Carcinoma
Multi-omics Technique
Nasopharyngeal Carcinoma
Efficacy of Chemoradiotherapy and Immunotherapy

Treatments

Drug: cisplatin-based chemoradiotherapy combined with immunotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT06197776
multi-omics technique in NPC

Details and patient eligibility

About

The observational clinical study will recruit 50 recurrent and/or metastatic nasopharyngeal carcinoma (r/mNPC) patients, to investigate the prediction values of multi-omics technique for the efficacy of chemoradiotherapy combined with immunotherapy.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recurrent or metastatic nasopharyngeal carcinoma patients
  • All genders,range from 18~70 years old
  • ECOG score 0 ~ 1
  • Inform consent form

Exclusion criteria

  • Have or are suffering from other malignant tumors;
  • Participating in other clinical trials;
  • Drug or alcohol addition;
  • Do not have full capacity for civil acts;
  • Mental disorder;
  • Pregnancy or lactation;
  • Severe complication, eg, uncontrolled hypertension.

Trial design

50 participants in 1 patient group

chemoradiotherapy combined with immunotherapy
Description:
Patients treated with chemoradiotherapy combined with immunotherapy
Treatment:
Drug: cisplatin-based chemoradiotherapy combined with immunotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Jingjing Miao, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems